-transparent.png){kind=logo}
Teleocidin (5 micrograms/mouse), a potent tumor promoting indole alkaloid from Streptomyces, induced epidermal ornithine decarboxylase (ODC) in CD-1 mice. Teleocidin-caused ODC induction was inhibited by the treatment of indomethacin (2 mumol/mouse), a selective cyclooxygenase inhibitor, and p-bromophenacyl bromide (BPB) (30 mumol/mouse), a phospholipase A2 inhibitor. Teleocidin-caused ODC induction inhibited by indomethacin was completely restored by concurrent application of prostaglandin E2 (PGE2) (140 nmol/mouse). On the other hand, teleocidin-caused ODC induction inhibited by BPB was not restored by the treatment of mice with PGE2, but partially restored by the treatment with arachidonic acid (1 mumol/mouse). Treatment of mice with lipoxygenase inhibitors such as BW755C (30 mumol/mouse), nordihydroguaiaretic acid (NDGA) (30 mumol/mouse), quercetin (10 mumol/mouse), and 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861) (10 mumol/mouse) clearly suppressed ODC induction by teleocidin. Moreover, both NDGA (30 mumol/mouse) and quercetin (10 mumol/mouse) inhibited the restoring effect of PGE2. Therefore, our present results suggest that arachidonate metabolites, i.e., not only cyclooxygenase product(s) but also lipoxygenase product(s), are involved in the mechanism of ODC induction by teleocidin.
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
July 1982,
Cancer research,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
November 1987,
European journal of pharmacology,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
January 1992,
Life sciences,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
April 1984,
Cancer research,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
January 2001,
Izvestiia Akademii nauk. Seriia biologicheskaia,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
January 1982,
Carcinogenesis,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
August 1985,
Osaka city medical journal,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
April 1997,
The American journal of physiology,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
July 1985,
Biochimica et biophysica acta,
T Nakadate, and
E Aizu, and
S Yamamoto, and
H Fujiki, and
T Sugimura, and
R Kato
November 1980,
Cancer research,
